Intelligent Bio Solutions Inc

INBS
2,36
0,05 (2,16%)
Ultimo aggiornamento: 16:32:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/5/202423:00EDGAR2Form 8-K - Current report
17/5/202414:30GLOBEInnovative Fingerprint Drug Screening Solution Showcased at..
08/5/202422:30EDGAR2Form 8-K - Current report
08/5/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:30GLOBEIntelligent Bio Solutions Inc. Reports Fiscal 2024 Third..
18/4/202414:30GLOBEIntelligent Bio Solutions Inc. Announces Preliminary..
11/4/202414:30GLOBEIntelligent Bio Solutions Subsidiary Broadens Intellectual..
26/3/202413:30GLOBEIntelligent Bio Solutions to Present at the LD Micro..
13/3/202400:30GLOBEIntelligent Bio Solutions Announces Closing of $10.1 Million..
11/3/202413:30GLOBEIntelligent Bio Solutions Announces $10.1 Million Private..
04/3/202423:26EDGAR2Form S-3 - Registration statement under Securities Act of..
01/3/202422:15EDGAR2Form 8-K - Current report
29/2/202423:00EDGAR2Form 8-K - Current report
28/2/202414:30GLOBEIntelligent Bio Solutions Partners with Cliantha Research to..
20/2/202423:05EDGAR2Form 8-K - Current report
16/2/202414:30GLOBEIntelligent Bio Solutions Inc. Regains Compliance with..
15/2/202400:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:05EDGAR2Form 8-K - Current report
09/2/202414:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202414:30GLOBEIntelligent Bio Solutions Inc. Reports Fiscal Second Quarter..
07/2/202423:05EDGAR2Form 8-K - Current report
05/2/202422:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202415:00GLOBEIntelligent Bio Solutions Inc. Announces Exercise of..
02/2/202423:15EDGAR2Form 8-K - Current report
02/2/202414:30GLOBEIntelligent Bio Solutions Inc. Announces Preliminary..
30/1/202423:05EDGAR2Form 8-K - Current report
30/1/202414:30GLOBEFingerprint Drug Test Delivers Quantifiable Benefits for..
29/1/202414:30GLOBELeading UK Timber Processor and Packaging Manufacturer,..
26/1/202423:05EDGAR2Form 8-K - Current report
25/1/202414:30GLOBEIntelligent Bio Solutions Inc. Announces Reverse Stock Split
22/1/202414:30GLOBEDGP Plc Takes Drug Testing In-house with Fingerprint..
18/1/202414:30GLOBEUK’s largest independent chemical manufacturer takes drug..
12/1/202423:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/1/202423:00EDGAR2Form 8-K - Current report
21/12/202323:15EDGAR2Form 8-K - Current report
19/12/202314:30GLOBEIntelligent Bio Solutions Receives NATA Accreditation for..
18/12/202322:20EDGAR2Form 8-K - Current report
14/12/202323:00EDGAR2Form 8-K - Current report
30/11/202314:30GLOBELeading Specialist Material Handling Company, Titan Cranes..
27/11/202314:30GLOBEAustralian Civil Construction Entity, State Road..
17/11/202323:15EDGAR2Form 8-K - Current report
17/11/202317:19EDGAR2Form DEF 14A - Other definitive proxy statements
16/11/202323:13EDGAR2Form ARS - Annual Report to Security Holders
08/11/202323:27EDGAR2Form 8-K - Current report
08/11/202322:21GLOBEIntelligent Bio Solutions Inc. Reports Fiscal 2024 First..
08/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:20EDGAR2Form PRE 14A - Other preliminary proxy statements
06/11/202323:00EDGAR2Form 8-K - Current report
24/10/202314:30GLOBEIntelligent Bio Solutions’ Innovative Drug Screening..
Apertura: 2,49 Min: 2,36 Max: 2,49
Chiusura: 2,31

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network